Matthew Sykes Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Matthew Sykes

Stock Analyst at Goldman Sachs

(3.53)
# 2602
Out of 5,478 analysts
243
Total ratings
Success rate
Average return
38 Stocks
Name Action PT Current % Upside Ratings Updated
FTRE Fortrea Holdings
Maintains: Neutral
7 5
10.1 -50.5% 4 May 14, 2025
CTKB Cytek Biosciences
Maintains: Sell
4 3
3.94 -23.86% 9 May 12, 2025
TXG 10x Genomics
Maintains: Sell
8 7
12.64 -48.58% 7 May 12, 2025
BRKR Bruker
Maintains: Neutral
50 45
30.91 45.58% 5 May 8, 2025
MYGN Myriad Genetics
Maintains: Buy
14 8
7.24 10.5% 12 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 48
25.31 89.65% 10 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
14 17
16.05 5.92% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
180 160
175 -8.57% 4 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 10
7.96 25.63% 8 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
140 125
82.88 50.82% 2 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
23 14
12.31 13.73% 6 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 240
190.07 26.27% 5 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 26
13.53 92.17% 10 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
190 170
152.92 11.17% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
49 56
54.9 2% 13 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 80
123.97 -35.47% 11 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
1.17 28.21% 5 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
160 190
168.51 12.75% 13 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
3 2
0.72 143.06% 5 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
7 5
2.67 59.18% 10 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
38 37
30.88 19.82% 5 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
75 65
53.94 20.5% 12 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
280 250
187.2 33.55% 2 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
23 7
20.01 -67.52% 11 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 24
4.81 398.96% 13 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1150 1300
1259.39 3.22% 5 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
32 12
9.99 20.12% 6 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
550 640
479.5 33.47% 4 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
128 145
n/a n/a 4 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1 1
n/a n/a 6 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
1 1
n/a n/a 8 Oct 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1 1
n/a n/a 2 May 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
16 18
26.08 -30.98% 5 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 2 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
200 175
115.24 51.86% 3 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
120 60
n/a n/a 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 4
2.43 64.61% 4 Apr 13, 2022